259 Changing trends in TNF inhibitor prescribing for axial spondyloarthritis: the influence of National Institute for Health and Care Excellence guidance

Kit Yee Wong; Max Yates; Chong Seng Edwin Lim; Karl Gaffney

doi:10.1093/rheumatology/kez107.075

259 Changing trends in TNF inhibitor prescribing for axial spondyloarthritis: the influence of National Institute for Health and Care Excellence guidance

Kit Yee Wong, Max Yates, Chong Seng Edwin Lim, Karl Gaffney

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Journal	Rheumatology
Volume	58
Issue number	Supplement_3
DOIs	https://doi.org/10.1093/rheumatology/kez107.075
Publication status	Published - 12 Apr 2019

Access to Document

10.1093/rheumatology/kez107.075Licence: Unspecified

Cite this

@article{8ccfa1b4437545bdbc70f98a43a3614e,

title = "259 Changing trends in TNF inhibitor prescribing for axial spondyloarthritis: the influence of National Institute for Health and Care Excellence guidance",

author = "Wong, {Kit Yee} and Max Yates and Lim, {Chong Seng Edwin} and Karl Gaffney",

year = "2019",

month = apr,

day = "12",

doi = "10.1093/rheumatology/kez107.075",

language = "English",

volume = "58",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "Supplement_3",

}

TY - JOUR

T1 - 259 Changing trends in TNF inhibitor prescribing for axial spondyloarthritis: the influence of National Institute for Health and Care Excellence guidance

AU - Wong, Kit Yee

AU - Yates, Max

AU - Lim, Chong Seng Edwin

AU - Gaffney, Karl

PY - 2019/4/12

Y1 - 2019/4/12

U2 - 10.1093/rheumatology/kez107.075

DO - 10.1093/rheumatology/kez107.075

M3 - Abstract

VL - 58

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - Supplement_3

ER -